These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 33141387)

  • 1. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Huang HL; Lin WC; Yeh CC; Sun YT
    J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.
    Xing X; Li A; Li C
    Respir Med; 2020 Oct; 172():106134. PubMed ID: 32905890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
    Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
    Respir Med; 2020; 165():105920. PubMed ID: 32174452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
    Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ
    Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
    Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
    Front Immunol; 2022; 13():879266. PubMed ID: 35603153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
    Huang HL; Lin WC; Lin PY; Weng MY; Sun YT
    Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease.
    Gui X; Shenyun S; Ding H; Wang R; Tong J; Yu M; Zhao T; Ma M; Ding J; Xin X; Qiu Y; Qiu X; Zhang Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
    Rheumatology (Oxford); 2022 Nov; 61(11):4570-4578. PubMed ID: 35148366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
    Zanatta E; Cocconcelli E; Castelli G; Giraudo C; Fraia AS; De Zorzi E; Gatto M; Ienna L; Treppo E; Malandrino D; Cereser L; Emmi G; Giannelli F; Bellani S; Martini A; Moccaldi B; Ghirardello A; Avouac J; Quartuccio L; Allanore Y; Doria A; Spagnolo P; Balestro E; Iaccarino L
    RMD Open; 2023 Aug; 9(3):. PubMed ID: 37541742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Weng CT; Huang TH; Wu CH; Sun YT
    Arthritis Res Ther; 2024 Aug; 26(1):152. PubMed ID: 39175076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
    Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
    Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
    Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
    Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
    Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia.
    Chartrand S; Swigris JJ; Peykova L; Chung J; Fischer A
    J Rheumatol; 2016 May; 43(5):887-92. PubMed ID: 26932342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review.
    Teel A; Lu J; Park J; Singh N; Basharat P
    Semin Arthritis Rheum; 2022 Dec; 57():152088. PubMed ID: 36116345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
    Buvry C; Cassagnes L; Tekath M; Artigues M; Pereira B; Rieu V; Le Guenno G; Tournadre A; Ruivard M; Grobost V
    Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody.
    Sclafani A; D'Silva KM; Little BP; Miloslavsky EM; Locascio JJ; Sharma A; Montesi SB
    Respir Res; 2019 Nov; 20(1):256. PubMed ID: 31718649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple values of
    Li Y; Zhou Y; Wang Q
    Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.